Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of signing consent.
- People who have been diagnosed with breast cancer (stages cT0-4, N1) confirmed through a tissue sample examination.
- People who have breast cancer that has spread to the lymph nodes under the arm, confirmed by a needle biopsy.
- People who have had a small metal clip placed in the affected underarm lymph node before chemotherapy started.
- People whose treatment plan includes chemotherapy before surgery.
- People whose care team has determined that a targeted underarm lymph node removal procedure (removing the clipped node and nearby sentinel lymph nodes) is planned after chemotherapy.
- People with a general health and activity level rated as reasonably functional (confirm with trial site for exact definition).
Who may not be able to join:
- People whose cancer has spread to distant parts of the body beyond the breast and nearby lymph nodes.
- People who have inflammatory breast cancer (a specific type where the breast becomes red and swollen).
- People who have previously had surgery on the underarm lymph nodes on the same side as the affected breast.
- People who have a previous history of breast cancer in the same breast being treated.
- People with a history of lymphoma (a type of cancer affecting the lymphatic system).
- People who are pregnant.
- People who have previously had radiation treatment to the breast or underarm area.
- People who have a pacemaker or other implanted heart device on the same side of the chest as the affected breast.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Abigail Caudle, MD, MS, MD Anderson Cancer Center, Houston, TX
Phone: +447851247439
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Retrieval rate of clipped node and Magseed in the excised specimen
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.